Skip to main content
SpringerLink
Log in

Beta-lactam allergy worsens outcomes and increases costs

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Huang KG, et al. The Impact of Reported Beta-Lactam Allergy in Hospitalized Patients with Hematologic Malignancies Requiring Antibiotics. Clinical Infectious Diseases : 16 Jan 2018. Available from: URL: http://doi.org/10.1093/cid/ciy037

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Beta-lactam allergy worsens outcomes and increases costs. PharmacoEcon Outcomes News 796, 8 (2018). https://doi.org/10.1007/s40274-018-4682-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-018-4682-z

Search

Navigation